Shanghai Conant Optical Co., Ltd. logo

Shanghai Conant Optical Co., Ltd.

2276.HK

HKSEHealthcareMedical - Instruments & Supplies

Latest quote

HK$41.10

+HK$1.14 · +2.85%

Aug 24, 11:59 AM HKT

2276.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Company website

Shanghai Conant Optical Co., Ltd. specializes in the global production and sale of resin eyeglass lenses. The company's extensive reach covers continents such as Asia, Europe, North and South America, Africa, and Oceania, in addition to its home market of China. It supplies a diverse range of optical solutions, including both standardized products and custom-tailored lenses. Its primary clientele consists of brand owners within the spectacle lens industry and various ophthalmic optics enterprises. The firm was established in 2011 and operates from its headquarters in Shanghai, China.

Industry
Medical - Instruments & Supplies
Sector
Healthcare
Headquarters
CN
CEO
Zhengxiang Fei
Listed since
Dec 16, 2021
Employees
3,231

Market position

Day range

Current HK$41.10

52-week range

Current HK$41.10

Open
HK$39.96
Previous close
HK$39.96
Volume
824.3K
0.33× average
Average volume
2.48M
Average daily volume
Market cap
19.87B HKD
Beta
0.31
Market reference 1
50-day average
HK$34.1452
+20.37% above average
200-day average
HK$47.8245
-14.06% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
22.16B CNY
P/E (TTM)
28.88×
P/B (TTM)
4.42×
P/S (TTM)
7.56×
EV / EBITDA
32.48×
Earnings yield
2.47%
Free cash flow yield
1.07%
Dividend yield
0.96%

Profitability & efficiency

Gross margin
42.91%
Operating margin
30.75%
Net margin
25.83%
Return on equity
20.32%
Return on assets
15.73%
Return on invested capital
16.99%

Financial health

Debt / equity
0.17×
Current ratio
3.59×
Altman Z-score
10.19
Piotroski F-score
5 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends45%33%22%11%Gross margin, FY2021: 33.93%Gross margin, FY2022: 34.45%Gross margin, FY2023: 37.40%Gross margin, FY2024: 38.58%Gross margin, FY2025: 41.97%Operating margin, FY2021: 15.40%Operating margin, FY2022: 15.37%Operating margin, FY2023: 21.95%Operating margin, FY2024: 23.68%Operating margin, FY2025: 27.57%Net margin, FY2021: 13.53%Net margin, FY2022: 15.92%Net margin, FY2023: 18.58%Net margin, FY2024: 20.78%Net margin, FY2025: 25.51%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 33.93%. Gross margin FY2022 34.45%. Gross margin FY2023 37.40%. Gross margin FY2024 38.58%. Gross margin FY2025 41.97%. Operating margin FY2021 15.40%. Operating margin FY2022 15.37%. Operating margin FY2023 21.95%. Operating margin FY2024 23.68%. Operating margin FY2025 27.57%. Net margin FY2021 13.53%. Net margin FY2022 15.92%. Net margin FY2023 18.58%. Net margin FY2024 20.78%. Net margin FY2025 25.51%.

Income trends

Revenue

2.19B CNY+6.08%

Operating income

602.68M CNY+23.53%

Net income

557.72M CNY+30.22%
Income trends across reported periods2.39B CNY1.59B CNY784.26M CNY−16.72M CNYRevenue, FY2021: 1.36B CNYRevenue, FY2022: 1.56B CNYRevenue, FY2023: 1.76B CNYRevenue, FY2024: 2.06B CNYRevenue, FY2025: 2.19B CNYOperating income, FY2021: 208.81M CNYOperating income, FY2022: 240.04M CNYOperating income, FY2023: 386.32M CNYOperating income, FY2024: 487.9M CNYOperating income, FY2025: 602.68M CNYNet income, FY2021: 183.52M CNYNet income, FY2022: 248.57M CNYNet income, FY2023: 327.02M CNYNet income, FY2024: 428.28M CNYNet income, FY2025: 557.72M CNYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 1.36B CNY. Revenue FY2022 1.56B CNY. Revenue FY2023 1.76B CNY. Revenue FY2024 2.06B CNY. Revenue FY2025 2.19B CNY. Operating income FY2021 208.81M CNY. Operating income FY2022 240.04M CNY. Operating income FY2023 386.32M CNY. Operating income FY2024 487.9M CNY. Operating income FY2025 602.68M CNY. Net income FY2021 183.52M CNY. Net income FY2022 248.57M CNY. Net income FY2023 327.02M CNY. Net income FY2024 428.28M CNY. Net income FY2025 557.72M CNY.
Metric (CNY)FY2025FY2024FY2023FY2022FY2021
Revenue2.19B CNY2.06B CNY1.76B CNY1.56B CNY1.36B CNY
Cost of goods sold1.27B CNY1.27B CNY1.1B CNY1.02B CNY895.92M CNY
Gross profit917.46M CNY795.1M CNY658.13M CNY537.87M CNY460.16M CNY
Research and development97.44M CNY95.78M CNY77.45M CNY65.83M CNY47.51M CNY
Selling, general, and administrative217.34M CNY323.78M CNY278.17M CNY224.71M CNY222.01M CNY
Operating expenses314.78M CNY307.2M CNY271.82M CNY297.83M CNY214.87M CNY
Interest income13.4M CNY5.87M CNY3.57M CNY2.43M CNY275K CNY
Interest expense6.01M CNY10.23M CNY13.65M CNY25.74M CNY34.95M CNY
Depreciation and amortization79.97M CNY74.44M CNY59.11M CNY47.69M CNY46.83M CNY
Operating income602.68M CNY487.9M CNY386.32M CNY240.04M CNY208.81M CNY
Net income557.72M CNY428.28M CNY327.02M CNY248.57M CNY183.52M CNY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
0.73

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates0.770.620.460.31Q4 '22Q2 '23Q2 '24Q2 '24Q4 '24Q3 '25Q1 '26Q3 '26
Q4 2022, reported Dec 31, 2022: actual 0.348, estimate —, surprise —, Comparison unavailable. Q2 2023, reported Jun 30, 2023: actual 0.402, estimate —, surprise —, Comparison unavailable. Q2 2024, reported Jun 4, 2024: actual 0.437, estimate —, surprise —, Comparison unavailable. Q2 2024, reported Jun 30, 2024: actual 0.535, estimate —, surprise —, Comparison unavailable. Q4 2024, reported Dec 31, 2024: actual 0.56, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 8, 2025: actual 0.645, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 30, 2026: actual 0.679, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 17, 2026: actual 0.733, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates1.41B1.22B1.03B844.55MQ4 '22No estimateQ2 '23No estimateQ2 '24No estimateQ2 '24No estimateQ4 '24No estimateQ3 '25No estimateQ1 '26BeatQ3 '26Beat
Q4 2022, reported Dec 31, 2022: actual 927.87M HKD, estimate —, surprise —, Comparison unavailable. Q2 2023, reported Jun 30, 2023: actual 898.83M HKD, estimate —, surprise —, Comparison unavailable. Q2 2024, reported Jun 4, 2024: actual 1.03B HKD, estimate —, surprise —, Comparison unavailable. Q2 2024, reported Jun 30, 2024: actual 1.05B HKD, estimate —, surprise —, Comparison unavailable. Q4 2024, reported Dec 31, 2024: actual 1.15B HKD, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 8, 2025: actual 1.19B HKD, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 30, 2026: actual 1.25B HKD, estimate 1.23B HKD, surprise +2.04%, Beat. Q3 2026, reported Aug 17, 2026: actual 1.36B HKD, estimate 1.33B HKD, surprise +2.08%, Beat.

2276.HK peers

ETFs holding 2276.HK

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research 2276.HK

research.disclaimer